
Sign up to save your podcasts
Or
We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease
4.9
129129 ratings
We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease
4,244 Listeners
2,265 Listeners
872 Listeners
2,833 Listeners
755 Listeners
722 Listeners
792 Listeners
809 Listeners
15,495 Listeners
8,598 Listeners
1,719 Listeners
257 Listeners
426 Listeners
686 Listeners
115 Listeners